D. E. Shaw & Co., Inc. Athersys, Inc Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.18 - $0.86 $90,565 - $432,702	-503,143 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.6 - $1.06 $301,885 - $533,331	503,143 New	503,143 $305,000
Q3 2020 Nov 16, 2020	SELL	$1.91 - $3.08 $91,765 - $147,978	-48,045 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.97 - $3.98 $34,146 - $68,985	17,333 Added 56.44%	48,045 $132,000
Q1 2020 May 15, 2020	BUY	$1.17 - $3.0 $35,933 - $92,136	30,712 New	30,712 $92,000
Q1 2018 May 15, 2018	SELL	$1.34 - $2.03 $128,602 - $194,823	-95,972 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.65 - $2.45 $76,830 - $114,081	46,564 Added 94.24%	95,972 $174,000
Q3 2017 Nov 14, 2017	BUY	$1.5 - $2.55 $74,112 - $125,990	49,408	49,408 $102,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.